Manuel Reina

Corporate Officer/Principal bei University of Barcelona

Consumer Services

Health Technology

Profil

Manuel Reina is a Director of Advanced In Vitro Cell Technologies SL.
He is an Associate Professor of Cell Biology at the University of Barcelona.
He is a Co-Director of Celltec UB and a Member of the Origami Society.
Dr. Reina received a PhD in Molecular Biology from CSIC, Barcelona.

Aktive Positionen von Manuel Reina

Unternehmen	Position	Beginn
University of Barcelona	Corporate Officer/Principal	-

Alle aktiven Positionen von Manuel Reina

Ehemalige bekannte Positionen von Manuel Reina

Unternehmen	Position	Ende
Advancell Advanced In Vitro Cell Technologies SL Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Manuel Reina im Detail an

Ausbildung von Manuel Reina

Consejo Superior de Investigaciones Científicas

Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Manuel Reina im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Advancell Advanced In Vitro Cell Technologies SL Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain.	Health Technology